Effect of Vitamin E on oxidative stress and outcome of treatment in patients of anxiety disorder

Sangita Devrao Jogdand, Raju Kamlakarrao Shinde


Background: The purpose of present study was to assess effect of Vitamin E administration on oxidative stress and outcome of treatment of anxiety disorder.

Methods: 80 newly diagnosed patients of anxiety disorder of age 20 to 60 years were included in the study. They were divided in to two groups containing 40 patients in each group. Group-I patients were given treatment with Tablet Clonazepam 0.5mg orally daily at night for six months. Group-II patients were treated with Tablet Clonazepam 0.5mgand Capsule Vitamin E 400 mg twice a day for 6 months. Levels of Mean MDA, SOD and anxiety score were assessed monthly for six months.

Results: Group-I (N=38) patients treated with Tablet Clonazepam 0.5mg orally at night show significant increase in Oxidative stress. Mean MDA- 18.80±0.37 increased to 27.97±0.81, SOD- 0.143±0.004 decreased to 0.111±0.004 and decrease in mean anxiety score from first month 12.44±1.24 to last month of treatment 2.55±0.72. In group-II patients(N=37) treated with Clonazepam and Vitamin E there was decrease in mean MDA levels from 18.78±0.45 to 12.56±0.54 and increase in mean SOD levels from 0.141±0.007 to 0.180±0.000. There was reduced anxiety score in group-I from 12.44±1.24 to 2.55±0.72 and in group II from 12.54±1.26 to 1.86±0.58 which was statistically significant. p value <0.05.

Conclusions: Treatment of patients treated with Clonazepam showed a significant increase in oxidative stress. In patients treated with Clonazepam and Vitamin E there was more reduction in overall oxidative stress and anxiety.


Anxiety disorder, Anxiety score, Oxidative stress

Full Text:



Krolow R, Arcego DM, Noschang C, Weis SN, Dalmaz C. Oxidative imbalance and anxiety disorders. Current neuropharmacology. 2014 Mar;12(2):193-204.

Shelton CI. Diagnosis and Management of Anxiety Disorders. J Am Osteopath Assoc. 2004;104(3,1):S2-5.

Trivedi JK, Gupta PK. An overview of Indian research in anxiety disorders. Indian J Psychiatry. 2010 Jan;52(1):S210-8.

Salim S. Oxidative Stress and Psychological Disorders. Curr Neuropharmacol. 2014 Mar;12(2):140-7.

Yoshikawa T, Naito Y. What is oxidative stress?. Japan Medical Association Journal. 2002;45(7):271-6.

Pham-Huy LA, He H, Pham-Huy C. Free Radicals, Antioxidants in Disease and Health. Int J Biomed Sci IJBS. 2008 Jun;4(2):89-96.

Farach FJ, Pruitt LD, Jun JJ, Jerud AB, Zoellner LA, Roy-Byrne PP. Pharmacological treatment of anxiety disorders: Current treatments and future directions. J Anxiety Disord. 2012 Dec;26(8):833-43.

Benzodiazepines: Uses, Side Effects, Interactions & Warnings Mar 3]. Available at:

Reena N, Deepti P, Shruti K. Markers of oxidative stress in generalized anxiety psychiatric disorder: therapeutic implications. Journal of Stress Physiology & Biochemistry. 2012;8(2).

Julian LJ. Measures of Anxiety. Arthritis Care Res. 2011. Available at:

Bal N, Acar ST, Yazici A, Yazici K, Tamer L. Altered levels of malondialdehyde and vitamin E in major depressive disorder and generalized anxiety disorder. Dusunen Adam. 2012 Sep 1;25(3):206.

Gautam M, Agrawal M, Gautam M, Sharma P, Gautam AS, Gautam S. Role of antioxidants in generalised anxiety disorder and depression. Indian J Psychiatry. 2012;54(3):244-47.

Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974 Sep 16;47(3):469-74.

Rizvi S, Raza ST, Ahmed F, Ahmad A, Abbas S, Mahdi F. The Role of Vitamin E in Human Health and Some Diseases. Sultan Qaboos Univ Med J. 2014 May;14(2):e157-65.

Karajibani M, Hashemi M, Montazerifar F, Dikshit M. Effect of vitamin E and C supplements on antioxidant defense system in cardiovascular disease patients in Zahedan, southeast Iran. J Nutr Sci Vitaminol (Tokyo). 2010;56(6):436-40.